Suplatast tosylate side) BX-795 displays higher growth inhibition

BX-795 displays higher growth inhibition with IC50 of 0

These actions of Mibefradil are consistent with K+ channel inhibition

Molecular Weight: 518

Proteomics

OSMI-4 reduces O-GlcNAc levels almost completely by 5 μM

Suplatast tosylate side) BX-795 displays higher growth inhibitionSuplatast tosylate, also known as Suplatast tosilate, is a Th2 cytokine inhibitor which is used as an antiallergic drug. Often used in the treatment of Kimura's disease. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T cells mediated IL 9 gene expression in toluene 2, 4 diisocyanate sensitized rats. uplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3